202 related articles for article (PubMed ID: 8528553)
1. RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.
Brown CM; MacKinnon AC; Redfern WS; Williams A; Linton C; Stewart M; Clague RU; Clark R; Spedding M
Br J Pharmacol; 1995 Sep; 116(2):1737-44. PubMed ID: 8528553
[TBL] [Abstract][Full Text] [Related]
2. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
MacKinnon AC; Redfern WS; Brown CM
Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
[TBL] [Abstract][Full Text] [Related]
3. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
4. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
6. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
7. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
Evans RG; Anderson WP
Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
11. [3H]p-aminoclonidine and [3H]idazoxan label different populations of imidazoline sites on rat kidney.
MacKinnon AC; Stewart M; Olverman HJ; Spedding M; Brown CM
Eur J Pharmacol; 1993 Feb; 232(1):79-87. PubMed ID: 8096190
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
14. An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
Houghton AK; Westlund KN
Neuroreport; 1996 Jun; 7(9):1497-501. PubMed ID: 8856706
[TBL] [Abstract][Full Text] [Related]
15. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.
Olmos G; Alemany R; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1994 Apr; 111(4):997-1002. PubMed ID: 8032628
[TBL] [Abstract][Full Text] [Related]
16. The role of imidazoline receptors in blood pressure regulation.
Hamilton CA
Pharmacol Ther; 1992; 54(3):231-48. PubMed ID: 1361236
[TBL] [Abstract][Full Text] [Related]
17. LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.
Alemany R; Olmos G; Escribá PV; Menargues A; Obach R; García-Sevilla JA
Eur J Pharmacol; 1995 Jul; 280(2):205-10. PubMed ID: 7589187
[TBL] [Abstract][Full Text] [Related]
18. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
19. Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites.
Polidori C; Gentili F; Pigini M; Quaglia W; Panocka I; Massi M
Eur J Pharmacol; 2000 Mar; 392(1-2):41-9. PubMed ID: 10748271
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
